Ebglyss 250 mg/2 ml

Ebglyss 250 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 69460. The authorisation holder is Almirall AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 August 2024 and the authorisation is limited until 29 August 2029. ATC code D11AH10 places the medicine in the group Other dermatological preparations.

  • Dispensing category B
  • Authorisation number 69460
  • ATC D11AH10
  • Biotechnological medicines
Authorisation data
Authorisation number69460
NameEbglyss 250 mg/2 ml
Full nameEbglyss 250 mg/2 ml, Injektionslösung in Fertigpen
Authorisation holderAlmirall AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeD11AH10
First authorisation30 August 2024
Authorisation validity29 August 2029
Strengths
No.NameDispensing categoryAuthorisation date
2Ebglyss 250 mg/2 ml, Injektionslösung in FertigpenB30 August 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11 x 2mlD11AH1007.15.0.B
22 x 2mlD11AH1007.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ebglyss 250 mg/2 ml authorised in Switzerland?

Yes. Ebglyss 250 mg/2 ml is authorised by Swissmedic under authorisation number 69460, data as of 01 September 2026. The authorisation is limited until 29 August 2029.

Which dispensing category does Ebglyss 250 mg/2 ml have?

Ebglyss 250 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ebglyss 250 mg/2 ml?

The authorisation holder is Almirall AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com